| Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair A Wilson, E Laurenti, G Oser, RC van der Wath, W Blanco-Bose, ... Cell 135 (6), 1118-1129, 2008 | 2288 | 2008 |
| IFNα activates dormant haematopoietic stem cells in vivo MAG Essers, S Offner, WE Blanco-Bose, Z Waibler, U Kalinke, ... Nature 458 (7240), 904-908, 2009 | 1555 | 2009 |
| VEGF gene delivery to myocardium: deleterious effects of unregulated expression RJ Lee, ML Springer, WE Blanco-Bose, R Shaw, PC Ursell, HM Blau Circulation 102 (8), 898-901, 2000 | 917 | 2000 |
| Lentiviral-mediated RNA interference T Abbas-Terki, W Blanco-Bose, N Déglon, W Pralong, P Aebischer Human gene therapy 13 (18), 2197-2201, 2002 | 457 | 2002 |
| The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans PA Andreux, W Blanco-Bose, D Ryu, F Burdet, M Ibberson, P Aebischer, ... Nature Metabolism 1 (6), 595-603, 2019 | 421 | 2019 |
| Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity E Laurenti, B Varnum-Finney, A Wilson, I Ferrero, WE Blanco-Bose, ... Cell stem cell 3 (6), 611-624, 2008 | 363 | 2008 |
| Dormant and self‐renewing hematopoietic stem cells and their niches A Wilson, GM Oser, M Jaworski, WE BLANCO‐BOSE, E Laurenti, ... Annals of the New York Academy of Sciences 1106 (1), 64-75, 2007 | 330 | 2007 |
| Purification of mouse primary myoblasts based on α7 integrin expression WE Blanco-Bose, CC Yao, RH Kramer, HM Blau Experimental cell research 265 (2), 212-220, 2001 | 200 | 2001 |
| C‐Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia WE Blanco‐Bose, MJ Murphy, A Ehninger, S Offner, C Dubey, W Huang, ... Hepatology 48 (4), 1302-1311, 2008 | 157 | 2008 |
| Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults A Singh, D D’Amico, PA Andreux, AM Fouassier, W Blanco-Bose, ... Cell Reports Medicine 3 (5), 2022 | 130 | 2022 |
| Safety assessment of Urolithin A, a metabolite produced by the human gut microbiota upon dietary intake of plant derived ellagitannins and ellagic acid J Heilman, P Andreux, N Tran, C Rinsch, W Blanco-Bose Food and Chemical Toxicology 108, 289-297, 2017 | 117 | 2017 |
| Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the … A Singh, D D’Amico, PA Andreux, G Dunngalvin, T Kern, W Blanco-Bose, ... European journal of clinical nutrition 76 (2), 297-308, 2022 | 75 | 2022 |
| Pten loss in the bone marrow leads to G-CSF–mediated HSC mobilization M Tesio, GM Oser, I Baccelli, W Blanco-Bose, H Wu, JR Göthert, ... Journal of Experimental Medicine 210 (11), 2337-2349, 2013 | 51 | 2013 |
| Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders CL Rinsch, W Blanco-Bose, B Schneider, C Thomas, C Sandi, J Auwerx, ... US Patent 9,872,850, 2018 | 26 | 2018 |
| Laminin-induced change in conformation of preexisting α7β1 integrin signals secondary myofiber formation WE Blanco-Bose, HM Blau Developmental Biology 233 (1), 148-160, 2001 | 25 | 2001 |
| Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof CL Rinsch, W Blanco-Bose, B Schneider, L Mouchiroud, D Ryu, ... US Patent 11,020,373, 2021 | 20 | 2021 |
| Orally administered urolithin A is safe and modulates muscle and mitochondrial biomarkers in elderly A Singh, P Andreux, W Blanco-Bose, D Ryu, P Aebischer, J Auwerx, ... Innovation in Aging 1 (suppl_1), 1223-1224, 2017 | 18 | 2017 |
| Inducing tolerance to a soluble foreign antigen by encapsulated cell transplants WE Blanco-Bose, BL Schneider, P Aebischer Molecular Therapy 13 (2), 447-456, 2006 | 9 | 2006 |
| Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders C Rinsch, W Blanco-Bose, B Schneider, C Thomas, C Sandi, J Auwerx, ... US Patent 10,485,782, 2019 | 7 | 2019 |
| Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders CL Rinsch, W Blanco-Bose, B Schneider, C Thomas, C Sandi, J Auwerx, ... US Patent 11,234,960, 2022 | 6 | 2022 |
